BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35334070)

  • 1. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
    Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
    Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y
    Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
    Zeng F; You S; Dai X
    Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
    Zhang D; Hua M; Zhang N
    Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
    Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F
    J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
    Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
    Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1.
    Chen C; Tang J; Xu S; Zhang W; Jiang H
    Biomed Res Int; 2020; 2020():2547902. PubMed ID: 32351986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
    Zhang Q; Wang Y
    Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
    Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
    J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior 
of Lung Squamous Cell Carcinoma H520 Cells].
    Gou L; He Y; Qiu P; Huang B
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H; Zhao Q; Tang Z
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis.
    Zhang W; Shi J; Cheng C; Wang H
    J Cell Physiol; 2020 Sep; 235(9):5962-5971. PubMed ID: 31960961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
    Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
    Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.